Back to search results

Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC)

Abroad (travel likely)RecruitingPHASE1

Conditions

Nodular Basal Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Equity Medical, Bowling Green, Kentucky, United States

  • Equity Medical, New York, New York, United States

  • Woden Dermatology, Phillip, Australian Capital Territory, Australia

  • Novatrials, Charlestown, New South Wales, Australia

  • Scientia Clinical Research, Randwick, New South Wales, Australia

  • Innovate Clinical Research, Waitara, New South Wales, Australia

  • FNQH Cairns Skin Cancer Clinic, Westcourt, Queensland, Australia

  • Translational Research Institute, Woolloongabba, Queensland, Australia

  • Veracity Clinical Research, Woolloongabba, Queensland, Australia

View source on ClinicalTrials.gov(opens in a new tab)